Xue W - Search Results

1

SSizer: Determining the Sample Sufficiency for Comparative Biological Study.

Li F, Zhou Y, Zhang X, Tang J, Yang Q, Zhang Y, Luo Y, Hu J, Xue W, Qiu Y, He Q, Yang B, Zhu F. Li F, et al. Among authors: xue w. J Mol Biol. 2020 May 15;432(11):3411-3421. doi: 10.1016/j.jmb.2020.01.027. Epub 2020 Feb 7. J Mol Biol. 2020. PMID: 32044343 Free article.

2

Identification of dual active agents targeting 5-HT1A and SERT by combinatorial virtual screening methods.

Wang P, Yang F, Yang H, Xu X, Liu D, Xue W, Zhu F. Wang P, et al. Among authors: xue w. Biomed Mater Eng. 2015;26 Suppl 1:S2233-9. doi: 10.3233/BME-151529. Biomed Mater Eng. 2015. PMID: 26406003

3

Identification of the inhibitory mechanism of FDA approved selective serotonin reuptake inhibitors: an insight from molecular dynamics simulation study.

Xue W, Wang P, Li B, Li Y, Xu X, Yang F, Yao X, Chen YZ, Xu F, Zhu F. Xue W, et al. Phys Chem Chem Phys. 2016 Jan 28;18(4):3260-71. doi: 10.1039/c5cp05771j. Phys Chem Chem Phys. 2016. PMID: 26745505

4

Exploring the Inhibitory Mechanism of Approved Selective Norepinephrine Reuptake Inhibitors and Reboxetine Enantiomers by Molecular Dynamics Study.

Zheng G, Xue W, Wang P, Yang F, Li B, Li X, Li Y, Yao X, Zhu F. Zheng G, et al. Among authors: xue w. Sci Rep. 2016 May 27;6:26883. doi: 10.1038/srep26883. Sci Rep. 2016. PMID: 27230580 Free PMC article.

5

Comparison of FDA Approved Kinase Targets to Clinical Trial Ones: Insights from Their System Profiles and Drug-Target Interaction Networks.

Xu J, Wang P, Yang H, Zhou J, Li Y, Li X, Xue W, Yu C, Tian Y, Zhu F. Xu J, et al. Among authors: xue w. Biomed Res Int. 2016;2016:2509385. doi: 10.1155/2016/2509385. Epub 2016 Jul 28. Biomed Res Int. 2016. PMID: 27547755 Free PMC article.

6

The Human Kinome Targeted by FDA Approved Multi-Target Drugs and Combination Products: A Comparative Study from the Drug-Target Interaction Network Perspective.

Li YH, Wang PP, Li XX, Yu CY, Yang H, Zhou J, Xue WW, Tan J, Zhu F. Li YH, et al. PLoS One. 2016 Nov 9;11(11):e0165737. doi: 10.1371/journal.pone.0165737. eCollection 2016. PLoS One. 2016. PMID: 27828998 Free PMC article.

7

Performance Evaluation and Online Realization of Data-driven Normalization Methods Used in LC/MS based Untargeted Metabolomics Analysis.

Li B, Tang J, Yang Q, Cui X, Li S, Chen S, Cao Q, Xue W, Chen N, Zhu F. Li B, et al. Among authors: xue w. Sci Rep. 2016 Dec 13;6:38881. doi: 10.1038/srep38881. Sci Rep. 2016. PMID: 27958387 Free PMC article.

8

NOREVA: normalization and evaluation of MS-based metabolomics data.

Li B, Tang J, Yang Q, Li S, Cui X, Li Y, Chen Y, Xue W, Li X, Zhu F. Li B, et al. Among authors: xue w. Nucleic Acids Res. 2017 Jul 3;45(W1):W162-W170. doi: 10.1093/nar/gkx449. Nucleic Acids Res. 2017. PMID: 28525573 Free PMC article.

9

Differentiating Physicochemical Properties between Addictive and Nonaddictive ADHD Drugs Revealed by Molecular Dynamics Simulation Studies.

Wang P, Zhang X, Fu T, Li S, Li B, Xue W, Yao X, Chen Y, Zhu F. Wang P, et al. Among authors: xue w. ACS Chem Neurosci. 2017 Jun 21;8(6):1416-1428. doi: 10.1021/acschemneuro.7b00173. Epub 2017 Jun 8. ACS Chem Neurosci. 2017. PMID: 28557437

10

Differentiating physicochemical properties between NDRIs and sNRIs clinically important for the treatment of ADHD.

Wang P, Fu T, Zhang X, Yang F, Zheng G, Xue W, Chen Y, Yao X, Zhu F. Wang P, et al. Among authors: xue w. Biochim Biophys Acta Gen Subj. 2017 Nov;1861(11 Pt A):2766-2777. doi: 10.1016/j.bbagen.2017.07.022. Epub 2017 Jul 27. Biochim Biophys Acta Gen Subj. 2017. PMID: 28757337

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,773 results

Search Page

Filters